Chloride intracellular channel protein 1 (CLIC1)

Molecular Classification

Ion channel, Chloride channel, Soluble/membrane-associated protein, Member of glutathione S-transferase structural superfamily

Other Names

CLIC1, Nuclear chloride ion channel 27 (NCC27), Chloride channel nuclear, Chloride intracellular channel 1, Chloride channel protein p64

Disease Roles

Cancer (e.g., bladder cancer, breast cancer, glioblastoma, hepatocarcinoma)Cell proliferation in neoplasiaMetastasis (especially cancer stem cell/metastatic potential)

Chloride intracellular channel protein 1 Overview

Chloride intracellular channel protein 1 (CLIC1) is a member of the chloride intracellular channel family. It is encoded by the CLIC1 gene and is structurally homologous to the glutathione S-transferase superfamily[1][2]. CLIC1 exists in both soluble (cytoplasmic/nuclear) and membrane-associated forms, with its insertion into cellular membranes enabling chloride ion conductance[2][8]. CLIC1 plays roles in various fundamental cellular processes, including regulation of membrane potential, cell volume, pH homeostasis, vesicular trafficking, and actin cytoskeleton dynamics[1][3][4][6]. It is expressed in many tissues and is upregulated in various malignancies, such as bladder, breast, liver, and brain cancers, where it is implicated in cell proliferation, tumor aggressiveness, metastasis, and cancer stem cell maintenance[5][7]. Due to its overexpression in tumors and involvement in cancer cell biology, CLIC1 is being investigated both as a potential therapeutic target and as a biomarker, though approved targeted therapies are lacking[5][7][6]. The physiological and pathophysiological mechanisms involving CLIC1 are still under active research, particularly regarding its redox regulation, ion channel activity, and possible protein-protein interactions[2][8].

Mechanism of Action

Drugs inhibiting CLIC1 (such as IAA-94): block chloride current, potentially affecting cell cycle, proliferation, and tumor growth [6] Proposed (investigational) targeting mechanism: Inhibition of CLIC1-mediated chloride conductance in cancer cells to suppress tumor cell proliferation and metastasis

Biological Functions

Chloride ion transport

Regulation of cell membrane potential

Regulation of cell volume

Maintenance of intracellular pH

Transepithelial transport

Signal transduction

Regulation of cell cycle

Cell proliferation

Actin cytoskeleton dynamics

Vesicular trafficking

Integrin recycling

Disease Associations

Cancer (e.g., bladder cancer, breast cancer, glioblastoma, hepatocarcinoma)

Cell proliferation in neoplasia

Metastasis (especially cancer stem cell/metastatic potential)

Potential marker for tumor aggressiveness and patient stratification

Safety Considerations

Biological roles of CLIC1 are incompletely understood; inhibition may affect multiple physiological processes, including cell volume regulation and cell cycle [5][7]
Potential risk of disrupting normal chloride transport and related homeostasis in non-target tissues

Interacting Drugs

No specific approved therapeutic drugs directly targeting CLIC1 identified in the provided references.

IAA-94 (inhibitor of chloride channels, used in research) [6]

Associated Biomarkers

Biomarker
Overexpression of CLIC1 in tumor tissue (e.g., bladder cancer, triple-negative breast cancer) as a prognostic biomarker [5][7]
Expression status for patient stratification in specific cancer subtypes [5][7]